Group One Trading
ROIV icon

Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.84M Buy
104,900
+27,278
+35% +$989K 0.01% 1597
2026
Q2 		$2.75M Buy
77,622
+38,350
+98% +$1.13M ﹤0.01% 1930
2026
Q1 		$1.09M Buy
+39,272
New +$1.01M ﹤0.01% 2628
2025
Q3 		– Sell
-37,316
Closed -$462K – 9044
2025
Q2 		$421K Buy
37,316
+36,101
+2,971% +$391K ﹤0.01% 3591
2025
Q1 		$12.3K Buy
+1,215
New +$13.1K ﹤0.01% 6123
2024
Q3 		– Sell
-44,604
Closed -$508K – 7265
2024
Q2 		$471K Sell
44,604
-5,064
-10% -$55.5K ﹤0.01% 2612
2024
Q1 		$524K Buy
+49,668
New +$536K ﹤0.01% 2683
2023
Q4 		– Sell
-71,687
Closed -$699K – 8081
2023
Q3 		$837K Buy
71,687
+53,413
+292% +$604K ﹤0.01% 2436
2023
Q2 		$184K Buy
+18,274
New +$163K ﹤0.01% 4021
2022
Q4 		– Sell
-11,100
Closed -$61.7K – 7973
2022
Q3 		$36K Buy
+11,100
New +$43K ﹤0.01% 5664

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Group One Trading's ROIV Position: Q3 2026 in Review

Group One Trading increased its Roivant Sciences (ROIV) stake by 35% in Q3 2026, buying an estimated $989K and bringing the position to 104,900 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #1597.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 10 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Group One Trading held 104,900 shares of Roivant Sciences worth $3.84M as of Q3 2026.
  • Group One Trading bought 27,278 Roivant Sciences shares in Q3 2026, an estimated $989K.
  • Roivant Sciences made up 0.01% of Group One Trading's portfolio in Q3 2026, its #1597 holding.
  • Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 10 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.